Estrogen receptor-positive breast cancer patient-derived xenografts
NCT02752893
This study established a PDX platform at Dartmouth to generate novel mouse models of ER+/HER2- breast cancer, which will be used to develop novel treatment strategies and dissect signaling pathways underlying drug sensitivity and resistance.